Pharmaceutical composition for radiation-induced lung injury as well as preparation method and application of pharmaceutical composition

Through the pharmaceutical compositions that are combined with traditional Chinese medicine theory, using drugs such as ginseng and fried bitter almonds, a pharmaceutical composition for the treatment of radioactive lung injury was prepared, which solved the complications and toxic side effects of existing treatment methods, and achieved the Significant therapeutic effects and safety.

CN118903319APending Publication Date: 2024-11-08THE THIRD PEOPLES HOSPITAL OF CHENGDU
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411034407.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Although existing treatment methods for radioactive lung injury such as adrenal corticosteroid combined with antibiotics can temporarily relieve symptoms, they have complications and toxic side effects, and are expensive, and lack effective and low-toxic prevention and treatment methods.

Method used

According to traditional Chinese medicine theory, a pharmaceutical composition is prepared by combining ginseng, fried bitter almonds, honeysuckle, patchouli, Houttuynia cordata, Viagra, samadhi, and licorice. The drug with synergistic effect is formed by decoction and extract preparation methods. Composition for the treatment of radioactive lung injury.

Benefits of technology

It significantly improves the treatment effect of radioactive lung injury, reduces toxic side effects, and provides a cost-effective and safe treatment plan.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the technical field of radiation-induced lung injury medicines. The invention provides a pharmaceutical composition for radiation-induced lung injury as well as a preparation method and application of the pharmaceutical composition. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 2-4 parts of ginseng, 10-14 parts of fried semen armeniacae amarae, 20-30 parts of honeysuckle, 8-10 parts of pogostemon cablin, 6-10 parts of houttuynia cordata, 4-6 parts of radix polygonati officinalis, 3-5 parts of sculellaria barbata and 1-3 parts of liquorice. According to the traditional Chinese medicine theory, the traditional Chinese medicine composition follows the principle of monarch, minister, assistant and guide during compatibility, monarch drugs, minister drugs, assistant drugs and guide drugs are used in cooperation, all the drugs in the components act synergistically, and the traditional Chinese medicine composition has the remarkable treatment effect on radiation-induced lung injury.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of radiation lung injury drugs, and in particular to a drug composition for radiation lung injury, a preparation method thereof and an application thereof. Background Art

[0002] Radiation lung injury is a complication caused by radiotherapy for malignant tumors in the chest. It is most common in radiotherapy for lung cancer and breast cancer, followed by radiotherapy for esophageal cancer and mediastinal malignant tumors. There is a history of radiotherapy for malignant tumors in the chest and related respiratory symptoms. Symptoms generally appear 4 to 16 weeks after the start of radiotherapy. Most of them occur within 2 to 4 weeks after the end of radiotherapy, and a few may occur within half a year after the end of radiotherapy. They are mainly dry cough, little sputum, difficulty swallowing, chest tightness, chest pain, and in severe cases, dyspnea, low fever, normal white blood cells, and antibacterial treatment is ineffective. In the acute stage, moist hiccups are heard in the irradiated lung field, and the breath sounds are rough. In the chronic stage, local percussion is dull. The breath sounds are low or fine moist hiccups are heard.

[0003] Once radiation-induced lung injury occurs, the most commonly used treatment method in clinical practice is the use of adrenocortical hormones combined with antibiotics. Although high-dose hormones can temporarily relieve symptoms and inhibit the development of pulmonary fibrosis, they are prone to many complications. The cytoprotectant amifostine can protect normal tissues to a certain extent, but it may have significant toxic side effects and is expensive. Therefore, finding more effective and less toxic methods to prevent and treat radiation-induced lung injury has become a research hotspot. Summary of the invention

[0004] The purpose of the present invention is to provide a pharmaceutical composition for radiation lung injury and a preparation method and application thereof. The Chinese medicine composition of the present invention is formulated according to the theory of traditional Chinese medicine and the principle of monarch, minister, assistant and messenger. The monarch drug, minister drug, adjuvant drug and messenger drug are used in combination, and each drug in the component acts synergistically, and has a significant therapeutic effect in treating radiation lung injury.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The invention provides a pharmaceutical composition for radiation lung injury. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 2-4 parts of ginseng, 10-14 parts of fried bitter almonds, 20-30 parts of honeysuckle, 8-10 parts of patchouli, 6-10 parts of houttuynia cordata, 4-6 parts of polygonatum, 3-5 parts of barbata scutellaria, and 1-3 parts of liquorice.

[0007] Preferably, the pharmaceutical composition is prepared from the following raw materials in parts by weight: 3 parts of ginseng, 12 parts of fried bitter almonds, 25 parts of honeysuckle, 9 parts of patchouli, 8 parts of houttuynia cordata, 5 parts of polygonatum, 4 parts of barbata, and 2 parts of licorice.

[0008] The present invention also provides a method for preparing the pharmaceutical composition, comprising the following steps:

[0009] (1) Weighing ginseng, fried bitter almonds, honeysuckle, patchouli, houttuynia cordata, polygonatum odoratum, scutellaria barbata and liquorice in proportion to obtain a mixed raw material;

[0010] (2) soaking the mixed raw materials in water and then boiling them, and filtering them to obtain a filtrate 1 and a filter residue;

[0011] (3) adding water to the filter residue and boiling it twice, and filtering to obtain filtrate 2;

[0012] (4) Filtrate 1 and filtrate 2 are combined and concentrated to obtain an extract.

[0013] Preferably, the mass ratio of the mixed raw materials to water during soaking in step (2) is 1:6-10, the soaking time is 30-45 minutes, and the decoction time is 20-40 minutes.

[0014] Preferably, in step (3), the mass ratio of the filter residue to water is 1:4-6, and the decoction time is 15-25 min.

[0015] Preferably, the density of the extract in step (4) is 1.2-1.3 g / cm 3 .

[0016] The present invention also provides application of the pharmaceutical composition in preparing products for radiation lung injury.

[0017] The present invention also provides a product for radiation-induced lung injury, and the pharmaceutical composition contained in the product.

[0018] Preferably, the product also contains pharmaceutically acceptable excipients.

[0019] Preferably, the product is in the form of granules or decoction.

[0020] The present invention provides a pharmaceutical composition for radiation lung injury and a preparation method and application thereof, wherein the pharmaceutical composition is prepared from the following raw materials in parts by weight: 2-4 parts of ginseng, 10-14 parts of fried bitter almonds, 20-30 parts of honeysuckle, 8-10 parts of patchouli, 6-10 parts of houttuynia, 4-6 parts of polygonatum, 3-5 parts of barbata, and 1-3 parts of licorice. The Chinese medicine composition of the present invention is formulated in accordance with the theory of traditional Chinese medicine, and follows the principle of monarch, minister, assistant and messenger, and uses monarch, minister, adjuvant and messenger drugs in combination, and each drug in the component acts synergistically, and has a significant therapeutic effect in treating radiation lung injury. DETAILED DESCRIPTION

[0021] The invention provides a pharmaceutical composition for radiation lung injury. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 2-4 parts of ginseng, 10-14 parts of fried bitter almonds, 20-30 parts of honeysuckle, 8-10 parts of patchouli, 6-10 parts of houttuynia cordata, 4-6 parts of polygonatum, 3-5 parts of barbata scutellaria, and 1-3 parts of liquorice.

[0022] In the present invention, the pharmaceutical composition is prepared from the following raw materials in parts by weight: 3 parts of ginseng, 12 parts of fried bitter almonds, 25 parts of honeysuckle, 9 parts of patchouli, 8 parts of houttuynia cordata, 5 parts of polygonatum, 4 parts of barbata, and 2 parts of licorice.

[0023] The present invention also provides a method for preparing the pharmaceutical composition, comprising the following steps:

[0024] (1) Weighing ginseng, fried bitter almonds, honeysuckle, patchouli, houttuynia cordata, polygonatum odoratum, scutellaria barbata and liquorice in proportion to obtain a mixed raw material;

[0025] (2) soaking the mixed raw materials in water and then boiling them, and filtering them to obtain a filtrate 1 and a filter residue;

[0026] (3) adding water to the filter residue and boiling it twice, and filtering to obtain filtrate 2;

[0027] (4) Filtrate 1 and filtrate 2 are combined and concentrated to obtain an extract.

[0028] In the present invention, the mass ratio of the mixed raw materials to water during soaking in step (2) is preferably 1:6-10, more preferably 1:8, the soaking time is preferably 30-45 min, more preferably 35-40 min, and the decoction time is preferably 20-40 min, more preferably 30 min.

[0029] In the present invention, the mass ratio of the filter residue to water in step (3) is preferably 1:4-6, more preferably 1:5, and the decoction time is preferably 15-25 min, more preferably 20 min.

[0030] In the present invention, the density of the extract in step (4) is preferably 1.2 to 1.3 g / cm 3 .

[0031] The present invention also provides application of the pharmaceutical composition in preparing products for radiation lung injury.

[0032] The present invention also provides a product for radiation-induced lung injury, and the pharmaceutical composition contained in the product.

[0033] In the present invention, the product preferably further contains pharmaceutically acceptable excipients.

[0034] In the present invention, the product is preferably in the form of granules or decoction.

[0035] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0036] Example 1

[0037] A method for preparing a pharmaceutical composition for radiation-induced lung injury comprises the following steps:

[0038] (1) Weigh ginseng, stir-fried bitter almonds, honeysuckle, patchouli, houttuynia, polygonatum, barbata and licorice in a weight ratio of 2 parts of ginseng, 14 parts of stir-fried bitter almonds, 30 parts of honeysuckle, 8 parts of patchouli, 10 parts of houttuynia, 4 parts of polygonatum, 3 parts of barbata and 3 parts of licorice to obtain a mixed raw material;

[0039] (2) adding 6 times the weight of water to the mixed raw materials, soaking for 45 minutes, decocting for 20 minutes, and filtering to obtain filtrate 1 and filter residue;

[0040] (3) adding 6 times the weight of water to the filter residue and boiling for 15 min, and filtering to obtain filtrate 2;

[0041] (4) Filtrate 1 and filtrate 2 were combined and concentrated to obtain a density of 1.2 g / cm 3 extract.

[0042] Example 2

[0043] A method for preparing a pharmaceutical composition for radiation-induced lung injury comprises the following steps:

[0044] (1) Weigh ginseng, stir-fried bitter almonds, honeysuckle, patchouli, houttuynia, polygonatum, barbata and licorice in a weight ratio of 4 parts of ginseng, 10 parts of stir-fried bitter almonds, 20 parts of honeysuckle, 10 parts of patchouli, 6 parts of houttuynia, 6 parts of polygonatum, 5 parts of barbata and 1 part of licorice to obtain a mixed raw material;

[0045] (2) adding 10 times the weight of water to the mixed raw materials, soaking for 30 minutes, decocting for 40 minutes, and filtering to obtain filtrate 1 and filter residue;

[0046] (3) adding 4 times the weight of water to the filter residue and boiling for 25 min, and filtering to obtain filtrate 2;

[0047] (4) Filtrate 1 and filtrate 2 were combined and concentrated to obtain a density of 1.3 g / cm 3 extract.

[0048] Example 3

[0049] A method for preparing a pharmaceutical composition for radiation-induced lung injury comprises the following steps:

[0050] (1) Weigh ginseng, stir-fried bitter almonds, honeysuckle, patchouli, houttuynia, polygonatum, barbata and licorice in a weight ratio of 3 parts of ginseng, 12 parts of stir-fried bitter almonds, 25 parts of honeysuckle, 9 parts of patchouli, 8 parts of houttuynia, 5 parts of polygonatum, 4 parts of barbata and 2 parts of licorice to obtain a mixed raw material;

[0051] (2) adding 8 times the weight of water to the mixed raw materials, soaking for 35 minutes, decocting for 30 minutes, and filtering to obtain filtrate 1 and filter residue;

[0052] (3) adding 5 times the weight of water to the filter residue and boiling for 20 min, and filtering to obtain filtrate 2;

[0053] (4) Filtrate 1 and filtrate 2 were combined and concentrated to obtain a density of 1.25 g / cm 3 extract.

[0054] Test example

[0055] 1. Experimental animals: 32 male C57BL / 6 mice were selected and divided into 4 groups, 8 mice in each group, numbered as experimental groups 1 to 3 and the control group.

[0056] 2. Experimental method: On the first day of the experiment, after anesthetizing C57BL / 6 mice, the lungs of the mice were irradiated with X-rays at a dose of 22.5Gy / 10min. The administration began on the second day, with the mice in test group 1 given the extract prepared in Example 1, the mice in test group 2 given the extract prepared in Example 2, the mice in test group 3 given the extract prepared in Example 3, and the mice in the control group not given additional medication. Each mouse was given 0.012g per day for 14 consecutive days, and mice in each group were free to drink water and eat. At the end of the experiment, the mice were killed to observe the condition of the lung tissue.

[0057] 3. Test results:

[0058] The alveolar septa of mice in the control group were significantly thickened and uneven in thickness, and the alveolar wall epithelial cells were degenerated, necrotic, and shed, with obvious damage.

[0059] The bronchioles, alveolar ducts, alveolar sacs, alveoli, and blood vessels in the lung tissues of mice in experimental groups 1 to 3 were normal with clear structures.

[0060] As can be seen from the above embodiments, the present invention provides a pharmaceutical composition for radiation lung injury and its preparation method and application, wherein the pharmaceutical composition is prepared from the following raw materials in parts by weight: 2-4 parts of ginseng, 10-14 parts of fried bitter almonds, 20-30 parts of honeysuckle, 8-10 parts of patchouli, 6-10 parts of houttuynia, 4-6 parts of polygonatum, 3-5 parts of barbata, and 1-3 parts of licorice. The Chinese medicine composition of the present invention is formulated in accordance with the theory of traditional Chinese medicine, following the principle of monarch, minister, assistant and messenger, and using monarch medicine, minister medicine, adjuvant medicine, and messenger medicine in combination, and each medicine in the component acts synergistically, and has a significant therapeutic effect in treating radiation lung injury.

[0061] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A pharmaceutical composition for radiation-induced lung injury, characterized in that: The pharmaceutical composition is prepared from the following raw materials in parts by weight: 2-4 parts of ginseng, 10-14 parts of fried bitter almonds, 20-30 parts of honeysuckle, 8-10 parts of patchouli, 6-10 parts of houttuynia cordata, 4-6 parts of polygonatum, 3-5 parts of barbata scutellaria, and 1-3 parts of licorice.

2. The pharmaceutical composition according to claim 1, characterized in that The pharmaceutical composition is prepared from the following raw materials in parts by weight: 3 parts of ginseng, 12 parts of fried bitter almonds, 25 parts of honeysuckle, 9 parts of patchouli, 8 parts of houttuynia cordata, 5 parts of polygonatum, 4 parts of barbata scutellaria, and 2 parts of liquorice.

3. The method for preparing the pharmaceutical composition according to claim 1 or 2, characterized in that: The steps include: (1) Weighing ginseng, fried bitter almonds, honeysuckle, patchouli, houttuynia cordata, polygonatum odoratum, scutellaria barbata and liquorice in proportion to obtain a mixed raw material; (2) soaking the mixed raw materials in water and then boiling them, and filtering them to obtain a filtrate 1 and a filter residue; (3) adding water to the filter residue and boiling it twice, and filtering to obtain filtrate 2; (4) Filtrate 1 and filtrate 2 are combined and concentrated to obtain an extract.

4. The preparation method according to claim 3, characterized in that: The mass ratio of the mixed raw materials to water during the soaking in step (2) is 1:6-10, the soaking time is 30-45 minutes, and the decoction time is 20-40 minutes.

5. The preparation method according to claim 4, characterized in that: In step (3), the mass ratio of the filter residue to water is 1:4-6, and the decocting time is 15-25 minutes.

6. The preparation method according to any one of claims 3 to 5, characterized in that: The density of the extract in step (4) is 1.2-1.3 g / cm 3 .

7. Use of the pharmaceutical composition according to claim 1 or 2 or the composition prepared by the preparation method according to any one of claims 3 to 6 in the preparation of products for radiation-induced lung injury.

8. A product for radiation lung injury, characterized in that: The product contains the pharmaceutical composition according to claim 1 or 2 or the composition prepared by the preparation method according to any one of claims 3 to 6.

9. The product according to claim 8, characterized in that The product also contains pharmaceutically acceptable excipients.

10. The product according to claim 8, characterized in that The product is in the form of granules or decoction.

Citation Information

Patent Citations

  • Application of traditional Chinese medicine composition in preparing medicine for treating radiation-induced pulmonary injury

    CN105079227A

  • Antiviral traditional Chinese medicinal composition as well as preparation method and application thereof

    CN111803583A

  • Plant beverage for conditioning and treating lung diseases and preparation method thereof

    CN112106839A

  • Antiviral and antibacterial traditional Chinese medicine composition containing herba houttuyniae as well as preparation method and application of antiviral and antibacterial traditional Chinese medicine composition

    CN114099584A